Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 4 Unknown 3 Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 9 Carcinoma, Non-Small-Cell Lung 8 Esophageal Squamous Cell Carcinoma 7 Stomach Neoplasms 4 Recurrence 4 Neoplasm Metastasis 4 Head and Neck Neoplasms 4 Lung Neoplasms 3 Colorectal Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Esophageal Neoplasms 2 Uterine Cervical Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Multiple Pulmonary Nodules 1 Mid-low Rectal Cancer 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Ipilimumab 114 pembrolizumab 95 Nivolumab 91 aldesleukin 86 Interleukin-2 57 Cyclophosphamide 54 Dacarbazine 52 Vemurafenib 39 trametinib 37 Temozolomide 37 incomplete Freund's adjuvant 35 fludarabine phosphate 35 sargramostim 32 dabrafenib 32 fludarabine 26 Bevacizumab 26 Paclitaxel 22 MART-1 Antigen 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 montanide ISA 51 20 Interferon-alpha 20 Cisplatin 20 Carboplatin 19 Sorafenib 18 Introns 17 Biopsy 17 cobimetinib 16 Radiosurgery 16 atezolizumab 15 Radiotherapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × tislelizumab × Clear all

NCT05542342 2026-06-01

SITISVEAL

Grupo Español Multidisciplinar de Melanoma

Phase 2 Completed

16 enrolled 14 charts

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡